Logo1
OH - 2nd Annual Medical Directors Forum: Spot on Personalized Health Management
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
Please rate the following:
Overall quality of the meeting.
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV.
Comfort of rooms.
How well did the educational sessions give a balanced view of therapeutic options, including the use of general names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain:
Please rate the expertise of the speaker - Susan W. Butterworth, PhD, MS.
Please rate the expertise of the speaker - Kevin J. Graham, MD, FACC.
Please rate the expertise of the speakers - Richard M. Bergenstal, MD.
Please rate the expertise of the speaker - William E. Boden, MD, FACC.

Please rate the expertise of the speaker - Sayeed Ikramuddin, MD.

Please rate the expertise of the speaker - John Whelchel, MD.
Please rate the expertise of the speakers - John P. Elliott, MD.
Objective: Determine the clinical and financial impact of wellness programs and behavioral management on large patient populations.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in performance changes in my professional practice.
Please rate the teaching ability of the speaker - Susan W. Butterworth, PhD, MS.
Please rate the teaching ability of the speaker - Kevin J. Graham, MD, FACC
Please rate the teaching ability of the speakers - Richard M. Bergenstal, MD.
Please rate the teaching ability of the speaker - William E. Boden, MD, FACC.
Please rate the teaching ability of the speaker - Sayeed Ikramuddin, MD.
Please rate the teaching ability of the speaker - John Whelchel, MD.
Please rate the teaching ability of the speakers - John P. Elliott, MD.
Objective: Outline best practices, current research and innovative approaches to improve outcomes and reduce costs in patients with chronic disease conditions
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in performance changes in my professional practice.
Please rate the speaker's responsiveness to questions:
Please rate the speaker's responsiveness to questions:
Please rate the speakers' responsiveness to questions:
Please rate the speaker's responsiveness to questions:
Please rate the speaker's responsiveness to questions:
Please rate the speaker's responsiveness to questions:
Please rate the speaker's responsiveness to questions:
Objective: Explore scientific and clinical advances in successfully managing maternal and newborn health, cervical cancer, end-stage renal disease and obesity.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in performance changes in my professional practice.
Discuss the impact of wellness programs on improving morale, reducing company healthcare costs and promoting prevention, wellness and healthy lifestyles.
Identify coaching strategies that are proven effective in creating behavior change and improved patient outcomes, and compare them to those that are less effective.
State theoretical models, industry trends and personalized approaches as keys to sustaining lasting behavioral change.

Identify new and innovative therapies to manage coronary artery disease (CAD), including the controversy surrounding the use of ezetimibe to lower cholesterol levels.

State the most clinically appropriate, cost-effective and timely diagnostic testing and procedures for CAD.
Explain the mechanism of action and effectiveness and controversies surrounding innovative therapies in the management of diabetes.
Explain how to organize therapy for type 2 diabetes into a systematic set of algorithms.
Review the randomized clinical trials that have assessed the role of optimal medical therapy (OMT) versus percutaneous coronary intervention (PCI) in patients with stable coronary artery disease (CAD) and angina pectoris.
Describe the results of the Clinical Outcomes Utilizing Revascularizaiton and Aggressive drug Evaluation (COURAGE Trial).
Develop and integrate evidence-based approaches to the initial and long-term management of symptomatic patients with stable CAD with respect to clinical event rate reduction.
Describe the link between information flow and material flow.

Discuss the appropriate peroperative regimen for patients undergoing bariatric surgery.

Identify approaches for the evaluation of morbid obesity in pediatrics and adolescents and recognize when members of this population become candidates for bariatric surgery.

Identify practices that can prevent or slow progression of chronic renal disease to end-stage renal failure.
State the advantages of renal transplantation over chronic dialysis for treatment of end stage renal disease.
Identify methods to reduce maternal and newborn morbidity and mortality.
Explore approaches that may be incorporated to improve antenatal care and appropriately affect behavior change in pregnant mothers.
Explore the importance of applying evidence-based therapies to engage consumers in the management of their CAD.
Discuss systems of care that can improve patient outcomes and the importance of teaching patients self -management skills.

State the role of minimally invasive surgery for obese patients.

Explore disparities in access to renal transplantation for African Americans with ESRD and methods to increase transplant access for this population.

Objective: List disparities in access to renal transplantation for African Americans with ESRD, and methods to increase transplant options for this population.
The above objective has increased my professional knowledge.
The above objective will increase my professional competence.
The above objective will result in performance changes in my professional practice.
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or individual speakers, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
If you have additional comments regarding the session or speaker, please use the space below:
Please answer the following:

Do you believe this activity was appropriate for the scope of your professional activities?

Do you believe this activity will result in your ability to improve your practice?
Was the educational content scientifically sound?
Was the educational content free of commercial bias?
If faculty spoke about off-label or investigational use of a product, was that information disclosed to you?
Was the mode of education effective to learning?
If you answered 'No' to any of the above questions, please explain:
Were you solicited by sales personnel in an educational room while you attended this educational activity?
If you answered 'Yes' to the above question, please explain:
What did you learn during this activity that you intend to integrate into your practice?

List any perceived practice "gaps" (educational needs/topics) which you would like to see the focus of future trainings.

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training be improved to impact your competence or practice?

Additional comments:

Only Florida licensees need to answer this question.  Notice to Florida Licensees:  In order for us to report your hours to CE Broker, you MUST provide us with your Florida alpha-numeric license number (e.g., PY1234, SS123, MH1234, MT1234).  Please be sure you enter this number accurately, or CE Broker will not record your hours.
Mr question